EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Transdermal Delivery of Botulinum Toxin for the Management of Oily and Acne‐Prone Skin Using TDA Technology

Stephanie Schulz iD, Sophie Lamprecht iD

Journal of Cosmetic Dermatology · 2026

DOI: 10.1111/jocd.70656 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2026. Verfasst von Stephanie Schulz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Meddrop BioMedical Technologies GmbH, Hamburg, Germany. Hauptthemen laut MEDLINE: Acne Vulgaris, Sebum, Botulinum Toxins, Type A. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intradermal botulinum toxin injections have been shown to reduce sebaceous gland activity and improve skin texture in patients with oily and acne‐prone skin. However, needle‐based application is associated with discomfort and potential side effects.

Objective

To evaluate the clinical efficacy and safety of transdermal delivery of botulinum toxin (150 kDa) using Transdermal Application (TDA) technology for the treatment of oily and acne‐prone skin.

Methods

In this single‐center observational study, 19 participants (aged 20–50) underwent treatment with the DERMADROP MED TDA device according to the BIOBOTOX protocol. Objective assessments included Sebumeter measurements and 2D/3D skin imaging. Subjective evaluation was conducted using validated patient‐reported outcome measures (OSIS, OSSAS) at baseline, 2 weeks, and 4 weeks posttreatment.

Results

A statistically significant reduction in sebum levels was observed, accompanied by notable improvements in self‐reported skin clarity and satisfaction. No adverse events were reported.

Conclusion

Transdermal application of botulinum toxin using TDA‐based DERMADROP MED technology is a safe, well‐tolerated, and effective noninvasive treatment modality for reducing sebaceous activity and improving the appearance of oily and acne‐prone skin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisSebumBotulinum Toxins, Type AHumansAdultFemaleAdministration, CutaneousYoung AdultMiddle AgedMalePatient SatisfactionTreatment OutcomePatient Reported Outcome MeasuresSkinSebaceous Glands

Substanzen

Botulinum Toxins, Type A

Autor:innen und Institutionen

  • Meddrop BioMedical Technologies GmbH, Hamburg, Germany.
  • Arc Clinic, Barcelona, Spain.

ORCID-Profile: Stephanie Schulz, Sophie Lamprecht

Zitieren

APA

Schulz, S., & Lamprecht, S. (2026). Transdermal Delivery of Botulinum Toxin for the Management of Oily and Acne‐Prone Skin Using TDA Technology. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70656

Vancouver

Schulz S, Lamprecht S. Transdermal Delivery of Botulinum Toxin for the Management of Oily and Acne‐Prone Skin Using TDA Technology. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70656

BibTeX
@article{Schulz2026,
  author = {Schulz, Stephanie and Lamprecht, Sophie},
  title = {Transdermal Delivery of Botulinum Toxin for the Management of Oily and Acne‐Prone Skin Using TDA Technology},
  journal = {Journal of Cosmetic Dermatology},
  year = {2026},
  doi = {10.1111/jocd.70656}
}
Kostenlos starten →